Liabilities / Assets
66th percentile
Tied with the lowest-debt nonprofits in its peer group.
990EZ • Fiscal year 2014 • EIN 20-2710571
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
66th percentile
Tied with the lowest-debt nonprofits in its peer group.
Liabilities / Revenue
64th percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
40th percentile
Higher net margin than 40% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
1st percentile
Faster asset growth than 1% of similar nonprofits.
Revenue Growth
97th percentile
Faster revenue growth than 97% of similar nonprofits.
Assets
Down$98
Down $4,469 (-98%) from 2013
Net Assets
-
No earlier filing loaded for comparison.
Liabilities
Flat$0
Flat from 2013
Revenue
Up$151,747
Up $131,109 (+635%) from 2013
Expenses
Up$156,215
Up $135,640 (+659%) from 2013
Net Income
Down-$4,468
Down $4,531 (-7192%) from 2013
This 2014 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
The mission of the organization is to accelerate the discovery and development of applications of new therapies for disease and translate those therapies into treatments for patients through the science of regenerative medicine. The organization focuses on obtaining federal and other grant funds and working with other organizations developing regenerative medicine and products to accomplish its mission.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2014 • Form 990EZSummary only. Only limited summary data is available for this year.